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1. Introduction 
The initiation of DNA-synthesis n lymphocytes by 
mitogens has been widely studied as a model for ini- 
tiation of the proliferation i resting cells. Several dif- 
ferent biochemical events have been described follow- 
ing shortly (within one hour) after exposure of lym- 
phocytes to mitogens, but the possible causal relations 
of these events to the initiation of DNA synthesis are 
still poorly understood [ 1 ]. Phytohaemagglutinin 
(PHA) induces an increased influx of calcium ions 
through the plasma membrane into the cells within a 
few minutes [2,3], and calcium ionophore itself acts 
as a mitogen for lymphocytes [4-6].  Another early 
event is a considerable increase of the levels of cyclic 
guanosine 3':5' monophosphate (cGMP) in the cells, 
detected within minutes of exposure to PHA [7]. 
These two processes may be causally related since the 
enzyme by which cGMP is synthesized is activated by 
calcium in other cells [8] as well as in lymphocytes 
(our unpublished observations). Although activation 
of protein kinases has been generally considered to be 
the main mechanism by which cyclic purine nucleo- 
tides participate in the regulation of cellular metabo- 
lism [9], other important modes of action may exist. 
Indeed, the enzyme responsible for the synthesis of 
phosphoribosyl pyrophosphate (PRPP), PRPP synthe- 
tase, was recently reported to be allosterically regulated 
by cyclic purine nucleotides [10]. Cyclic cGMP was a 
potent stimulator of the enzyme, while cAMP com- 
petitively inhibited the stimulation by cGMP [ 10]. 
PRPP is a common precursor for both the de novo 
and the 'salvage' pathways of purine biosynthesis in
mammalian cells [! 1,12]. PRPP concentration is con- 
sidered to be one of the main regulators of the first 
enzyme in the novo pathway, glutamine-phosphorib- 
osyl pyrophosphate amidotransferase [13], and 
thereby an important effector of the overall rate of 
purine biosynthesis. 
Activation of purine biosynthesis could be the way 
by which mitogens initiate DNA synthesis in lympho- 
cytes. This hypothesis supported by our present data, 
which show that PHA induces a rapid increase in the 
coficentration of PRPP in cultured human peripheral 
blood lymphocytes. 
2. Materials and methods 
2.1. Cell cultures 
Human peripheral blood lymphocytes were purified 
from buffy coats of healthy persons by a modification 
of the Ficoll-Hypaque technique [14], as described 
in detail elsewhere [6]. The final cell suspensions, 
containing more than 95% trypan blue excluding 
mononuclear leucocytes, were incubated at 37°C in 
RPMI-1640 medium supplemented with 10% foetal 
calf serum. A small volume of PHA in phosphate 
buffered saline was added to a final concentration f
2 #g/ml, and the cells were incubated at a density of 
5 × 106 cells/ml in a humidified atmosphere (5% v/v 
CO2 in air). 
2.2. PRPP measurement 
To measure cellular PRPP pools 50-100 × 106 
cells per sample were harvested by centrifugation, 
washed twice with phosphate buffered saline and 
frozen as a cell pack at -20°C until assayed. Imme- 
diately before the assay the cell pack was thawed, one 
volume of distilled water was added, and the cells 
were broken by ultrasonic treatment. The homo- 
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genates were then centrifuged for 15 rain at 4000 g 
at 4°C. The supernatants were assayed for PRPP 
concentration enzymatically using either exogeneous 
hypoxanthine-guanine phosphoribosyl transferase 
(HGPRTase) [15] or the endogenous adenine phos- 
phoribosyl transferase (APRTase) [16] and the corre- 
sponding 14C-labelled cosubstrates, hypoxanthine or
adenine. In both methods the reaction was stopped 
by addition of excess EDTA and cooling immediately 
to 0°C. The monophosphates were separated by high 
voltage lectrophoresis in 0.02 M sodium lactate pH 
3.6 at 7 kV for 25 min. The spots, co-electrophoresed 
with IMP or AMP, were located by u.v. light, cut out 
and counted for radioactivity in a toluene-based scin- 
tillation fluid with an efficiency of about 75%. 
2.3. Sources and special properties of reagents used 
The buffy coats were kindly provided by the North 
London Blood Transfusion Centre, Edgware, Middlesex 
Purified phytohaemagglutinin type HA 16 was from 
Wellcome Reagents Limited, Beckenham, UK. RPMI- 
1640 and foetal calf serum were supplied by GIBCO- 
BioCult, Paisley, Scotland. [14C]adenine and [14C] 
hypoxanthine were from the Radiochemical Centre, 
Amersham, UK. HGPRTase was purified from human 
erythrocytes according to the method of Krenitsky et 
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Fig.1. Time course of the PHA-induced increase inPRPP 
concentration in human peripheral b ood lymphocytes. HPB 
lymphocytes were cultured with 2 t~g]ml PHA at 37°C. 
Aliquots of 6 × 107 cells were harvested atthe times indi- 
cated and assayed for PRPP by using the endogenous 
APRTase enzyme (see Material and methods) (o-o) Non- 
stimulated cells; (o-o) PHA-treated cells. Mean of duplicate 
samples i given. 
level, although the absolute values of PRPP concen- 
tration observed using the endogenous APRTase 
were slightly higher than those obtained by the exog- 
eneous HGPRTase method. 
4. Discussion 
3. Results 
The low level of PRPP in unstimulated human 
peripheral blood lymphocytes did not change signifi- 
cantly during the observation period. Adding 2/ag/ml 
of PHA to the cell cultures caused a rapid increase in 
the level of PRPP, detectable after 5 min and reaching 
a maximum at 15 to 20 min (fig.l). Later on the con- 
centration of PRPP decreased to the level of the un- 
stimulated cells. This type of rapid and transient 
increase was observed in aU four experiments carried 
out with duplicate samples. In one experiment, how- 
ever, the level of PRPP was three-fold that of the 
control cultures at 15 min and was still elevated at 
60 rain. Three of these experiments were carried out 
using the endogenous APRTase enzyme and one 
using exogeneous HGPRTase. Both methods gave a 
similar pattern of the PHA-induced increase of PRPP 
We have shown that exposure of human peripheral 
blood lymphocytes to phytohaemagglutinin at the 
optimal mitogenic oncentration causes a rapid 
increase of the cellular levels of phosphoribosylpyro- 
phosphate, a precursor and regulator of the novo path- 
way of purine biosynthesis. It is important to note 
that the observed time-course in the PHA-induced 
increase of PRPP concentration is similar to that 
reported for the PHA-induced change in the level of 
cGMP in human lymphocytes [7]. Thus, our results 
suggest that cGMP may also stimulate PRPP synthe- 
tase in intact lymphocytes. Increased PRPP level in 
mitogen-stimulated lymphocytes may activate the 
biosynthesis of purine nucleotides, an event which 
may be a necessary prerequisite for the initiation of 
a new cell cycle. The fact that the observed increase 
of PRPP concentration decayed rapidly may be a 
reflection of secondarily increased utilization of PRPP 
An alternative explanation is that only a pulse of 
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PRPP and purine biosynthesis  needed to push a 
resting lymphocyte from Go to G1. 
The relative importance of the de novo pathway of 
purine biosynthesis and interconversions of purine 
nucleotides for the proliferation of lymphocytes i
pinpointed by the well known value of purine deriv- 
atives as immunosuppressants and in anti-leukaemia 
chemotherapy [12], and by the fact that a congenital 
lack of adenosine deaminase l ads to a severe 
combined immunodeficiency [ 18]. While this work 
was in progress Chambers et al. reported Concanavalin 
A-induced activation of the de novo pathway of 
purine biosynthesis n mouse spleen cell cultures, 
detected 8 hr after adding the mitogen [19], and 
increased PRPP levels have been observed in human 
peripheral blood lymphocytes incubated for 3 days 
with PHA [20]. Our work is the first in which in- 
creased PRPP concentration has been associated with 
the early events of the mitogenic response of lympho- 
cytes. Whether this change results in an early activa- 
tion of purine biosynthesis n mitogen-stimulated lym- 
phosytes, remains to be shown by further studies. 
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